Clinical application of pharmacogenetics in gastrointestinal diseases

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

As knowledge of the human genome grows, there will be a direct impact on the management of specific diseases. Within gastroenterology and hepatology, there has been a change in the understanding of how variations or mutations in genes involved in drug metabolism or disease pathophysiology affect response to therapy. This review discusses the application of clinical pharmacogenetics to the following diseases and disorders: inflammatory bowel disease, Helicobacter pylori infections, gastroesophageal reflux disease, irritable bowel syndrome, functional dyspepsia, liver transplantation and colon cancer. Although only a few genotyping tests are regularly used in clinical practice, it is anticipated that studies will propel the routine use of many of the tests described in this review, in the future.

Original languageEnglish (US)
Pages (from-to)1857-1869
Number of pages13
JournalExpert Opinion on Pharmacotherapy
Volume7
Issue number14
DOIs
StatePublished - Oct 2006

Fingerprint

Gastrointestinal Diseases
Pharmacogenetics
Gastroenterology
Irritable Bowel Syndrome
Dyspepsia
Helicobacter Infections
Human Genome
Liver Neoplasms
Disease Management
Gastroesophageal Reflux
Inflammatory Bowel Diseases
Helicobacter pylori
Liver Transplantation
Colonic Neoplasms
Mutation
Pharmaceutical Preparations
Genes
Therapeutics

Keywords

  • Drug metabolism
  • Drug toxicity
  • Pharmacogenetics
  • Pharmacogenomics
  • Polymophisms

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Clinical application of pharmacogenetics in gastrointestinal diseases. / Saito Loftus, Yuri Ann; Camilleri, Michael.

In: Expert Opinion on Pharmacotherapy, Vol. 7, No. 14, 10.2006, p. 1857-1869.

Research output: Contribution to journalArticle

@article{8d252bcc227140a3af11242ebfd071f2,
title = "Clinical application of pharmacogenetics in gastrointestinal diseases",
abstract = "As knowledge of the human genome grows, there will be a direct impact on the management of specific diseases. Within gastroenterology and hepatology, there has been a change in the understanding of how variations or mutations in genes involved in drug metabolism or disease pathophysiology affect response to therapy. This review discusses the application of clinical pharmacogenetics to the following diseases and disorders: inflammatory bowel disease, Helicobacter pylori infections, gastroesophageal reflux disease, irritable bowel syndrome, functional dyspepsia, liver transplantation and colon cancer. Although only a few genotyping tests are regularly used in clinical practice, it is anticipated that studies will propel the routine use of many of the tests described in this review, in the future.",
keywords = "Drug metabolism, Drug toxicity, Pharmacogenetics, Pharmacogenomics, Polymophisms",
author = "{Saito Loftus}, {Yuri Ann} and Michael Camilleri",
year = "2006",
month = "10",
doi = "10.1517/14656566.7.14.1857",
language = "English (US)",
volume = "7",
pages = "1857--1869",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "14",

}

TY - JOUR

T1 - Clinical application of pharmacogenetics in gastrointestinal diseases

AU - Saito Loftus, Yuri Ann

AU - Camilleri, Michael

PY - 2006/10

Y1 - 2006/10

N2 - As knowledge of the human genome grows, there will be a direct impact on the management of specific diseases. Within gastroenterology and hepatology, there has been a change in the understanding of how variations or mutations in genes involved in drug metabolism or disease pathophysiology affect response to therapy. This review discusses the application of clinical pharmacogenetics to the following diseases and disorders: inflammatory bowel disease, Helicobacter pylori infections, gastroesophageal reflux disease, irritable bowel syndrome, functional dyspepsia, liver transplantation and colon cancer. Although only a few genotyping tests are regularly used in clinical practice, it is anticipated that studies will propel the routine use of many of the tests described in this review, in the future.

AB - As knowledge of the human genome grows, there will be a direct impact on the management of specific diseases. Within gastroenterology and hepatology, there has been a change in the understanding of how variations or mutations in genes involved in drug metabolism or disease pathophysiology affect response to therapy. This review discusses the application of clinical pharmacogenetics to the following diseases and disorders: inflammatory bowel disease, Helicobacter pylori infections, gastroesophageal reflux disease, irritable bowel syndrome, functional dyspepsia, liver transplantation and colon cancer. Although only a few genotyping tests are regularly used in clinical practice, it is anticipated that studies will propel the routine use of many of the tests described in this review, in the future.

KW - Drug metabolism

KW - Drug toxicity

KW - Pharmacogenetics

KW - Pharmacogenomics

KW - Polymophisms

UR - http://www.scopus.com/inward/record.url?scp=33749332041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749332041&partnerID=8YFLogxK

U2 - 10.1517/14656566.7.14.1857

DO - 10.1517/14656566.7.14.1857

M3 - Article

C2 - 17020413

AN - SCOPUS:33749332041

VL - 7

SP - 1857

EP - 1869

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 14

ER -